Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Ichnos grants Almirall global rights to develop and commercialize ISB-880 for autoimmune diseases

Dec. 14, 2021

New Wnt signaling activators identified at Biosplice Therapeutics

Dec. 9, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Targeting TWEAK shows potential as alternative therapeutic strategy for psoriasis

Dec. 2, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Vyne reports preclinical data on effect of VYN-201 on skin healing and repair

Nov. 5, 2021

Studies show that psoriasis is more than skin-deep

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026